Add Company
Join Now

Cardior Pharmaceuticals Revenue and Competitors

License our Company Data API

Hanover,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cardior Pharmaceuticals's estimated annual revenue is currently $6.8M per year.(i)
  • Cardior Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Cardior Pharmaceuticals has 44 Employees.(i)
  • Cardior Pharmaceuticals grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

Cardior is an academic spin-off from Medical School Hannover (MHH). Founded in 2016, a Series A financing round of 15 mn. EUR was successfully closed in May 2017. The company is focused on the development and clinical validation of noncoding (ncRNA) RNA therapeutics for patients with myocardial infarction and heart failure.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$6.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cardior Pharmaceuticals News

2022-04-06 - Movers & Shakers, April 8 | BioSpace

Cardior Pharmaceuticals: Russel Grieg was named independent chairman of the board of directors at Cardior. Greig brings more than 35 years...

2022-04-06 - Cardior Appoints Dr. Russell Greig as Independent Chairman of the ...

HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M4410%N/A
#2
$11.6M445%N/A
#3
$10.8M44-8%N/A
#4
$6.3M45-8%N/A
#5
$3.7M46-8%N/A